BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $4,046,000 | -0.2% | 29,360 | +0.6% | 0.52% | -5.6% |
Q3 2021 | $4,056,000 | +45.0% | 29,197 | +1.4% | 0.55% | +44.1% |
Q2 2021 | $2,797,000 | +40.6% | 28,808 | -1.0% | 0.38% | +35.6% |
Q1 2021 | $1,989,000 | -17.0% | 29,102 | +4.1% | 0.28% | -24.7% |
Q4 2020 | $2,395,000 | +34.9% | 27,944 | +2.3% | 0.37% | +10.7% |
Q3 2020 | $1,776,000 | – | 27,325 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |